Difference between revisions of "Yang X, et al, Lancet Respir Med (2020), cited as Ref 52 in DOI:10.1007/s11886-020-01292-3 (Q10561)"
Jump to navigation
Jump to search
(Created claim: Publication Date (P100): 2020, #quickstatements; #temporary_batch_1592504869652) |
(Created claim: Published In Name String (P102): Lancet Respir Med, #quickstatements; #temporary_batch_1592505200825) |
||
| Property / Published In Name String | |||
| + | Lancet Respir Med | ||
| Property / Published In Name String: Lancet Respir Med / rank | |||
| + | Normal rank | ||
Revision as of 18:34, 18 June 2020
Cited in: "Cardiovascular Complications in Patients with COVID-19: Consequences of Viral Toxicities and Host Immune Response" Research article published in Curr Cardiol Rep; 2020 04 21 ; 22 (5) 32.
| Language | Label | Description | Also known as |
|---|---|---|---|
| English |
Yang X, et al, Lancet Respir Med (2020), cited as Ref 52 in DOI:10.1007/s11886-020-01292-3
|
Cited in: "Cardiovascular Complications in Patients with COVID-19: Consequences of Viral Toxicities and Host Immune Response" Research article published in Curr Cardiol Rep; 2020 04 21 ; 22 (5) 32.
|
Statements
Q10356 (Deleted Item)
0 references
Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan China: a single-centered retrospective observational study (English)
0 references
Yang X
0 references
Yu Y
0 references
Xu J
0 references
Shu H
0 references
Xia J
0 references
Liu H
0 references
2020
0 references
Lancet Respir Med
0 references
